首页> 外文期刊>Retina >Macular and peripapillary choroidal thickness in diabetic patients
【24h】

Macular and peripapillary choroidal thickness in diabetic patients

机译:糖尿病患者的黄斑和乳突周围脉络膜厚度

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To investigate macular and peripapillary choroidal thickness (CT) in diabetic patients with and without diabetic retinopathy (DR). METHODS: One hundred and fifty subjects were enrolled: 102 diabetic patients (102 eyes) and 48 normals, as controls. Exclusion criteria were previously treated DR, refractive error higher than ±3 diopters, and treated or untreated glaucoma. All patients underwent full ophthalmic examination, stereoscopic color fundus photography, and spectral domain optical coherence tomography (RS-3000; Nidek). Spectral domain optical coherence tomography examination consisted of linear scans, 6 mm in length, centered onto the fovea, and circle scan positioned around the optic disk (3.46 mm in diameter). Choroidal thickness was measured manually at the fovea and at 1, 2, and 3 mm distance along all scans in the macula. Peripapillary CT was measured at eight points along the circle scan. All measurements were performed independently by 2 masked graders. RESULTS: Mean age was not significantly different between patients with diabetes and controls. In the macular area, CT was significantly lower in the nasal quadrant versus all other quadrants (P < 0.0001), in both groups. In the peripapillary area, CT was significantly lower in the inferior quadrant versus all other quadrants (P < 0.05), in both groups. Mean macular and peripapillary CT progressively and significantly decreased with increasing level of DR (nonproliferative and proliferative DR vs. controls, P < 0.05). No significant CT difference was found between controls and diabetic eyes without detectable DR. Diabetic macular edema did not influence CT. Interobserver coefficient of repeatability was 28.8 (95% confidence interval, 24.8-32.8) for foveal measurements and 13.0 (95% confidence interval, 11.2-14.8) for peripapillary measurements. Pearson correlation coefficient was 0.99, and P <0.0001 for all measurements. CONCLUSION: Choroidal thickness is reduced in diabetic eyes and parallels appearance and evolution of DR. Spectral domain optical coherence tomography clearly confirms in vivo previously reported histopathologic observations. The role of choroid in the pathophysiology of DR needs to be adequately investigated.
机译:目的:探讨患有和不患有糖尿病性视网膜病变(DR)的糖尿病患者的黄斑和乳头状脉络膜脉络膜厚度(CT)。方法:150名受试者入选:102例糖尿病患者(102眼)和48名正常人作为对照。排除标准为先前接受过DR治疗,屈光度高于±3屈光度以及接受过或未接受过治疗的青光眼。所有患者均接受了全面的眼科检查,立体彩色眼底照相和光谱域光学相干断层扫描(RS-3000; Nidek)。光谱域光学相干断层扫描检查包括长度为6 mm,以中央凹为中心的线性扫描和围绕视盘(直径3.46 mm)定位的圆形扫描。人工测量黄斑中心凹处以及沿黄斑部所有扫描的1、2和3 mm距离处的脉络膜厚度。沿圆形扫描在八个点测量了乳头周CT。所有测量均由2名蒙面分级员独立进行。结果:糖尿病患者和对照组之间的平均年龄没有显着差异。在黄斑区域,两组的鼻象限CT均显着低于所有其他象限(P <0.0001)。在两组之间,在乳头周围区域中,CT的CT值显着低于所有其他象限(P <0.05)。黄斑和乳头周围平均CT逐渐升高,并随着DR水平的升高而显着降低(非增生性DR和增生性DR与对照组相比,P <0.05)。在无可检测的DR的对照组和糖尿病眼之间未发现明显的CT差异。糖尿病性黄斑水肿不影响CT。中央凹测量的观察者间重复性系数为28.8(95%置信区间,24.8-32.8),乳头周围测量为13.0(95%置信区间,11.2-14.8)。皮尔森相关系数为0.99,所有测量值的P <0.0001。结论:糖尿病眼的脉络膜厚度减少,并与DR的出现和发展相平行。光谱域光学相干断层扫描清楚地证实了体内先前报道的组织病理学观察结果。脉络膜在DR病理生理中的作用需要进行充分研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号